Food News and Research

RSS

Avioq receives premarket approval from FDA for Avioq HIV-1 Microelisa System

Avioq, Inc. announced it has received premarket approval from the U.S. Food and Drug Administration (FDA) for the Avioq HIV-1 Microelisa System.

1 Dec 2009

Stryker to acquire Ascent Healthcare Solutions

Stryker Corporation today announced a definitive agreement to acquire privately held Ascent Healthcare Solutions, Inc. the market leader in the reprocessing and remanufacturing of medical devices in the U.S.

From Stryker 1 Dec 2009

Investigators identify effective weight control strategies for overweight adolescents

Adolescent obesity is a major public health problem that impacts one out of every three children, resulting in 4-5 million overweight youth in the United States. In a study published in the December 2009 issue of the Journal of the American Dietetic Association, researchers evaluated differences in weight control behaviors, including dietary intake and physical activity, comparing overweight adolescents who lost weight and those who did not in order to better understand which strategies could be most effective.

1 Dec 2009

PanGenex plans to expand its retail product line with the addition of spirulla

PanGenex Corporation, a global nutraceutical and dietary supplement manufacturer and marketer, announced today that it has solidified plans to expand its retail product line with the addition of spirulla.

1 Dec 2009

Neurotoxic heavy metal can slow the progression of Lou Gehrig's disease

New discoveries have been made about how an elevated level of lead, which is a neurotoxic heavy metal, can slow the progression of amyotrophic lateral sclerosis, or Lou Gehrig's disease - findings that could point the way to a new type of therapy.

1 Dec 2009

Commonwealth leaders' meeting concludes; includes discussion about health

Leaders issued a statement covering a variety of topics, including health, after a three-day Commonwealth Heads of Government Meeting concluded Sunday in Port of Spain, the capital of Trinidad and Tobago, Xinhua reports (Manda, 11/30).

30 Nov 2009

British First Lady highlights maternal mortality worldwide

Sarah Brown, wife of British Prime Minister Gordon Brown and head of the Maternal Mortality Campaign, highlighted global maternal mortality at the Royal College of Midwives annual conference on Friday, the U.K. Press Association reports.

30 Nov 2009

Also in Global Health news: 'Positive deviance' approach to health; child malnutrition in Madagascar; Somalia's health system; weak harvests in West Africa; improving health equity

The Boston Globe examines "'positive deviance,' an approach to behavioral and social change. Instead of imposing solutions from without, the method identifies outliers in a community who, despite having no special advantages, are doing exceptionally well. By respecting local ingenuity, proponents say, the approach galvanizes community members and is often more effective and sustainable than imported blueprints."

30 Nov 2009

GLUMETZA patent infringement lawsuit against Lupin

Depomed, Inc. today announced that it has filed a lawsuit in the United States District Court for the Northern District of California against Lupin Limited and its wholly-owned subsidiary, Lupin Pharmaceuticals, Inc., for infringement of the patents listed in the Orange Book for GLUMETZA® (metformin hydrochloride extended release tablets).

30 Nov 2009

QRxPharma commences Phase 3 pivotal trial of MoxDuo IR

QRxPharma Limited announced today, as part of its Phase 3 program, the initiation of a registration (also called pivotal) trial (Study 008) comparing efficacy and safety profiles of MoxDuo(TM)IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery. The Company expects to complete dosing by close of Q2 2010.

30 Nov 2009

BioMarin Pharmaceutical receives FDA orphan drug designation for 3,4-DAP

BioMarin Pharmaceutical Inc. announced today that the Food and Drug Administration (FDA) has granted orphan drug designation for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has previously received orphan drug designation in the E.U.

30 Nov 2009

Eli Lilly's Cymbalta receives FDA approval

The U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the maintenance treatment of generalized anxiety disorder (GAD) in adults, announced Eli Lilly and Company (NYSE: LLY).

30 Nov 2009

Acsys Interactive's recommendations to the FDA on social media in the healthcare industry

At the invitation of the Food and Drug Administration, Stan Valencis, President of Acsys Interactive, recently presented a series of recommendations to help shape the government's policy towards the promotion of prescription drugs, biologics and medical devices using the Internet and social media tools. As a leader in providing digital marketing and interactive strategies to healthcare systems, hospitals, device manufacturers and pharmaceutical companies, Acsys Interactive was selected by the FDA to provide its uniquely qualified perspective and experience.

30 Nov 2009

Spectrum Pharmaceuticals completes enrollment in apaziquone Phase 3 trial

Spectrum Pharmaceuticals today announced that one of the two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target, having enrolled approximately 800 patients with non-invasive bladder cancer. The second Phase 3 clinical trial of apaziquone is expected to complete enrollment by the end of the year.

30 Nov 2009

WALFA project demonstrates alternative way to mitigate climate change

A landmark Australian project that mitigates the extent and severity of natural savannah blazes by deploying traditional Indigenous fire management techniques is being hailed as a model with vast global potential in the fights against climate change and biodiversity loss, and for protecting Indigenous lands and culture.

30 Nov 2009

Canon U.S.A. to showcase digital printing solution at RSNA 2009

At the 2009 Radiological Society of North America Annual Meeting (RSNA 2009), Canon U.S.A., Inc., a leader in digital advanced imaging technologies (Booth #8339), will showcase the Canon imagePRESS C1+ digital printing solution with Virtual Imaging’s CYPHER, which is a DICOM printer server, a DICOM print solution which has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) .

30 Nov 2009

Intellivest Securities Research publishes a Report on BioClinica

Intellivest Securities Research, Inc., ("ISR") a Georgia registered investment advisor, has published a Report on BioClinica, Inc. ( BIOC) which serves companies in the pharmaceutical, biotechnology and medical device industries.

30 Nov 2009

EMEA determines MAA for omacetaxine mepesuccinate for treatment of CML patients

ChemGenex Pharmaceuticals Limited announced today that the European Medicines Agency ("EMEA") has determined that the Marketing Authorization Application ("MAA") for omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia (CML) patients who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation is valid.

28 Nov 2009

Agriflu approved to prevent diseases caused by influenza virus subtypes A and B

The U.S. Food and Drug Administration today approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.

27 Nov 2009

Dr. Gail Harrison to receive the March of Dimes Agnes Higgins Award

A nutritionist whose research was instrumental in adding fruits and vegetables to the federal Women, Infants and Children (WIC) food subsidy will receive the March of Dimes Agnes Higgins Award for outstanding achievement in the field of maternal-fetal nutrition.

27 Nov 2009